Form 4 for RMD ResMed|
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-03 · accession 0001127602-21-028432 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-05 | 2021-11-03 | RMD | PENDARVIS DAVID | Chief Administrative Off | S - Sale | $264.29 | -1,485 | 121.0K | -1% | -$392.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-11-03 | S | D | 1,485 | $264.29 | 120,987 | D | — | — |